Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: J Cardiol. 2011 Aug 4;58(2):124–130. doi: 10.1016/j.jjcc.2011.06.007

Table 2.

Atrial Fibrillation and Flutter Outcomes & Risk Determination candidate predictors

Predictor Ascertainment & definition Operational definition Type* Degrees of freedom
Age Interview and EMR review Value in years c 3
Sex Interview Female/Male d 1
2 hour resting heart rate Bedside monitor Value in beats per minute c 3
Maximum heart rate in first 2 hours of ED treatment Bedside monitor Value in beats per minute C 3
Requires iv drug infusion Review of EMR and electronic order tracker Yes/No D 1
Heart failure EMR & Echo results Yes/No D 1
Diabetes Interview and EMR review Yes/No D 1
Valvular heart disease EMR & Echo results Yes/No D 1
History of CVA or TIA Interview and EMR review Yes/No D 1
Takes >2 AV node blocker medications Interview and EMR review Yes/No D 1
Home warfarin use Interview and EMR review, INR Yes/No D 1
Home digoxin use Interview and EMR review, digoxin level Yes/No D 1
Dyspnea in ED Interview and EMR review Yes/No D 1
Palpitations in ED Interview and EMR review Yes/No D 1
Atrial flutter on ECG Review of ECG and EMR Yes/No D 1
BNP Core laboratory test Laboratory value C 2
BUN Core laboratory test Laboratory value C 2
Troponin I Core laboratory test Laboratory value C 2
Overall Degrees of Freedom 27
*

Type of variable: c = continuous; d = dichotomous; AV, atrioventricular; BNP, B-type natriuretic peptide; BUN, blood urea nitrogen; CVA, cerebrovascular accident; ECG, electocardiography; Echo, echocardiography; ED, emergency department; EMR, electronic medical record; INR, international normalized ratio; TIA, transient ischemic attack.